DyoDelta Biosciences
DyoDelta Biosciences Ltd., is a London based company specializing in deals in the Pharma / Biotech sector. We provide best-practice in corporate transactions through our management and associates. DyoDelta Biosciences is an elite group of senior executives with actual deal-making experience in the pharma and biotech industry at the corporate HQ level. We work closely with our clients/partners to put together collaborations in the life sciences.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Lucid Group Communications Limited
WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes.
MDNT
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
INmune Bio establishes global commercialization framework for Ebstrocel™ through strategic agreement with Uniphar
Press Releases | October 26, 2026 | Uniphar
Initial focus on named-patient access in selected European and MENA markets, providing a capital-efficient foundation for broader commercialization
Going private: what our year taught me about the patients pharma hasn’t yet spotted
White Papers and Resources | October 26, 2026 | 11 London
A thought piece on the rise of private healthcare, and why brands should help new kinds of patients and HCPs
Redefining Pediatric Epilepsy Care: Why We Must Move Beyond Symptom Suppression
Press Releases | October 21, 2026 | Medscape Education
For families navigating pediatric epilepsy, the condition dictates every moment of their lives. The constant, crippling "anticipatory anxiety" of when the next seizure might hit transforms daily activities like grocery...
What the Most Favored Nation (MFN) policy means for UK Pharma
White Papers and Resources | October 20, 2026 | Amiculum
By Jed Avissar and Manca Povsic
ANTHEM strengthens team with three appointments following Healthy Influence launch
Press Releases | October 19, 2026 | Resonant Group
Healthcare communications consultancy welcomes new talent as it invests in its next phase of growth
Access The Vector Issue 3: 15 payers describe the likely affect of EU General Pharmaceutical Legislation on orphan drug strategy
Press Releases | October 14, 2026 | Genesis Research Group
In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they believe the new EU General Pharmaceutical Legislation will...
Your AI pilot works. That’s the problem.
White Papers and Resources | October 14, 2026 | 11 London
What breaks when you scale it won't be the model. It'll be your data.
“We’ve been told we can’t touch AI”
White Papers and Resources | October 14, 2026 | 11 London
It's not been a great few weeks for anyone trying to make the calm, sensible case for AI tools. Researchers have been quitting the big labs, including Anthropic, and going...
What 90 Minutes of Live AI Case Practice Revealed About Physician Readiness
Press Releases | October 12, 2026 | Medscape Education
At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the practical and ethical use of AI. The format was case-based. The faculty presented...
On GLOBE Final Rule
Press Releases | October 9, 2026 | Genesis Research Group
The publication of the GLOBE Final Rule provides important clarity on the administration's approach to MFN pricing and what it could mean for pharmaceutical pricing, reimbursement, and access strategy globally....